L3VLUP
ProSign in

DMRA in the 13F filings

Damora Therapeutics Inc · CUSIP 36322Q206

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025
Quarter end
30 Jun 2026
the date the book describes
Filed
2 Sep 2026
latest of these filings; the earliest 13 Aug 2026
Managers listing it
14
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q1 2026 and Q2 2026; 3 listed it in both
Shares listed
16,510,255
combined, among listed positions
Reported value
$429m
combined, at the quarter end

AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.

Among the 91 comparable managers: 8 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,737,218.

Managers listing DMRA in Q2 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

14 of 14 holders

ActionFiling
Fidelity (FMR LLC)9,232,979$240munder 0.1%Added+187,49813 Aug 2026 (the filing on sec.gov)
Viking Global Investors LP2,311,082$60m0.17%Held014 Aug 2026 (the filing on sec.gov)
Janus Henderson Group Ltd2,282,804$59munder 0.1%Trimmed-79,89214 Aug 2026 (the filing on sec.gov)
Balyasny Asset Management LLC1,229,127$32munder 0.1%Trimmed-218,87314 Aug 2026 (the filing on sec.gov)
Wellington Management Group LLP1,058,000$28munder 0.1%Held014 Aug 2026 (the filing on sec.gov)
Citadel Advisors LLC166,347$4.3munder 0.1%Newnew2 Sep 2026 (the filing on sec.gov)
AllianceBernstein LP55,710$1.4munder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
Point72 Asset Management LP48,754$1.3munder 0.1%Trimmed-1,144,95414 Aug 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc48,743$1.3munder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
Invesco Ltd31,774$826kunder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
Verition Fund Management LLC12,140$316kunder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
Susquehanna International Group LLP12,009$312kunder 0.1%Added+2,23914 Aug 2026 (the filing on sec.gov)
Squarepoint Ops LLC11,668$303kunder 0.1%Trimmed-11,79014 Aug 2026 (the filing on sec.gov)
Two Sigma Investments LP9,118$237kunder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2026 to Q2 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (6)

Exited (6)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q4 2025 to 2 in Q2 2026
Drawing every quarter on file…

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

DMRA and LLY →DMRA and JNJ →DMRA and VRTX →Choose a stock to compare with DMRA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own DMRA, latest filings →Back to the 13F Explorer →